Skip to main content
OpenTrials

Clinical trial condition

Intellectual Disability

Explore clinical trials studying Intellectual Disability. Study availability and eligibility vary by location and protocol.

705 public trials 135 recruiting studies
Refine in advanced search Browse all conditions

Intellectual Disability trial results

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

NCT05322096

Conditions
Abnormalities, Multiple, Body Weight, Chromosome Disorders, +16 more
Locations
  • Rady Children's Hospital-San Diego San Diego, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Maimonides Medical Center Brooklyn, New York, United States
  • NYU Langone Hospital-Long Island Mineola, New York, United States
View all 23 locations
View Trial Details
Completed

A Study to Evaluate Ketamine for the Treatment of Rett Syndrome

NCT03633058

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations
  • University of Alabama Birmingham School of Medicine Birmingham, Alabama, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

NCT03852498

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +22 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Hôpital Robert Debré Paris, France
View Trial Details
Completed

Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period

NCT03714373

Conditions
Abnormalities, Multiple, Chromosome Disorders, Congenital Abnormalities, +13 more
Locations
  • University of California, Irvine Orange, California, United States
  • Stanford University Palo Alto, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 28 locations
View Trial Details

Related conditions